John M. Climaco

CIK: 0001546797

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

CNSP

CNS Pharmaceuticals, Inc.

DirectorOfficer

MBRX

Moleculin Biotech, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

CNSP
CNS Pharmaceuticals, Inc.
Nov 17, 2025
Award(A)
Option to purchase common stock
Direct
9.8K shares-
MBRX
Moleculin Biotech, Inc.
Nov 12, 2025
Award(A)
Stock Options (right to buy)
Direct
150K shares-
MBRX
Moleculin Biotech, Inc.
Nov 4, 2024
Award(A)
Stock option (right to buy)
Direct
10K shares-

		Type	Shares	Price		Ownership
Nov 17, 2025	CNSP CNS Pharmaceuticals, Inc.	Award(A) Option to purchase common stock	9,761	-	-	Direct
Nov 12, 2025	MBRX Moleculin Biotech, Inc.	Award(A) Stock Options (right to buy)	150,000	-	-	Direct
Nov 4, 2024	MBRX Moleculin Biotech, Inc.	Award(A) Stock option (right to buy)	10,000	-	-	Direct

1-3 of 3 transactions

About Climaco John M

Climaco John M (SEC CIK 0001546797) files insider reports with the SEC as Chief Executive Officer of CNS Pharmaceuticals, Inc. (CNSP) and Director of Moleculin Biotech, Inc. (MBRX).

Signal8 holds 3 ownership filings by Climaco John M, all Form 4s, filed between Nov 6, 2024 and Nov 19, 2025. Those filings report 3 transactions, from Nov 4, 2024 to Nov 17, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Climaco John M's filings is in HOUSTON, TX.

Recent filings by Climaco John M

Nov 17, 2025: Grant or award of CNSP derivative securities (Form 4, code A).
Nov 12, 2025: Grant or award of MBRX derivative securities (Form 4, code A).
Nov 4, 2024: Grant or award of MBRX derivative securities (Form 4, code A).

Other insiders filing for CNS Pharmaceuticals, Inc. (CNSP)

Fisher Michal, Director
Levin Rami, CEO and President
Charles Faith L., Director
Faulkner Eric, Chief Technology Officer
O'Loughlin Steve, Chief Financial Officer
Keyes Jeffry R., Director

How to read Form 4 transaction codes